Carlos E. de Andrea
- Immunology top 5%
- Oncology top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Co-authors
- Ignacio MeleroPancras C.W. HogendoornJudith V.M.G. BovéeMaría VillalbaJosé I. EchevesteÁlvaro TeijeiraMaría D. LozanoMaría C. Ochoa
- Topics
- Cancer Immunotherapy and Biomarkers (13 papers)Immunotherapy and Immune Responses (10 papers)Bone Tumor Diagnosis and Treatments (9 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Carlos E. de Andrea
47 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Immunology 434
- Oncology 418
- Molecular Biology 381
- Pulmonary and Respiratory Medicine 338
- Cancer Research 209
Countries citing papers authored by Carlos E. de Andrea
This map shows the geographic impact of Carlos E. de Andrea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos E. de Andrea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos E. de Andrea more than expected).
Fields of papers citing papers by Carlos E. de Andrea
This network shows the impact of papers produced by Carlos E. de Andrea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos E. de Andrea. The network helps show where Carlos E. de Andrea may publish in the future.
Co-authorship network of co-authors of Carlos E. de Andrea
This figure shows the co-authorship network connecting the top 25 collaborators of Carlos E. de Andrea. A scholar is included among the top collaborators of Carlos E. de Andrea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos E. de Andrea. Carlos E. de Andrea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Cross-priming in cancer immunology and immunotherapybreakdown → | 33 |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 5 | |
| 6 | 4 | |
| 7 | 0 | |
| 8 | 5 | |
| 9 | 6 | |
| 10 | 6 | |
| 11 | 16 | |
| 12 | 28 | |
| 13 | 36 | |
| 14 | 1 | |
| 15 | 36 | |
| 16 | 29 | |
| 17 | 15 | |
| 18 | 54 | |
| 19 | 2 | |
| 20 | 51 |
About Carlos E. de Andrea
Carlos E. de Andrea is a scholar working on Immunology, Rheumatology and Oncology, having authored 50 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), Immunotherapy and Immune Responses (10 papers) and Bone Tumor Diagnosis and Treatments (9 papers). The work is most often cited by research in Immunology (434 citations), Oncology (418 citations) and Cancer Research (209 citations). Carlos E. de Andrea has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Ignacio Melero, Pancras C.W. Hogendoorn, Judith V.M.G. Bovée, María Villalba, José I. Echeveste, Álvaro Teijeira, María D. Lozano, María C. Ochoa, Pedro Berraondo and Miguel F. Sanmamed. Their work appears in journals such as Nature Genetics, Journal of Clinical Oncology and Nature reviews. Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.